With a revenue increase of 393.78% in the second quarter 2026, year on year to cumulative value of $1,077 million, Insmed Inc's revenue per employee grew on a trailing twelve months basis to $ 646,978, this marks a new company high.
Within the Healthcare sector Employees of 209 other companies have achieved higher revenue per employee. While Insmed Inc's total ranking has deteriorated compared to the previous quarter from 1191 to 1799. Insmed Inc has 1,664 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

INSM Revenue per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Revenue Change	393.78 %	301.22 %	287.83 %	77.99 %	24.06 %
Sales per Employee (TTM) $	646,978	443,063	314,079	205,591	173,475
INSM's Total Ranking	# 1799	# 1191	# 330	# 279	# 953
Seq. Revenue Change	48.83 %	17.53 %	99.45 %	41.53 %	20.93 %

INSM Company Profile >> Back to INSM Efficiency Comparisons >> Compare INSM Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 118
Healthcare Sector	# 210
Overall Market	# 1799

Revenue per Employee Statistics
High	Average	Low
$ 646,978	$ 172,768	$ 60,453
(Jun 30 2026)		(Sep 30 2019)

Financial Statements
Insmed Inc's Revenue MRQ	$ 425 Millions	Visit INSM's Income Statement
Insmed Inc's Revenues TTM	$ 1,077 Millions	Visit INSM's aggregate revenue growth
What are INSM's Sales?		Visit INSM's Sales by Segment

Other Ratios
Insmed Inc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
INSM's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for INSM's Competitors
Revenue per Employee for INSM's Suppliers
Revenue per Employee for INSM's Customers

You may also want to know
INSM's Sales Growth Rates	INSM's Pe Price to earnings ratio	INSM's Receivables Turnover Ratio	INSM's Stock Quote
INSM's Net Income Growth Rates	INSM's Ps Price to Sales ratio	INSM's Sales per Employee	INSM's Asset Turnover Ratio
INSM's Net Margin	INSM's Pb Price to Book ratio	INSM's Financial Strength Ratios	INSM's Dividend Payout Ratio

Date modified: 2026-09-08T13:52:09+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2026	Number of Employees Jun 30 2026
Akebia Therapeutics Inc	1,129,175.26	$ 219.060 Million	194
Siga Technologies Inc	1,095,079.92	$ 53.659 Million	49
Biomarin Pharmaceutical Inc	1,057,626.20	$ 3,406.614 Million	3,221
Hims and Hers Health Inc	1,055,894.35	$ 2,578.494 Million	2,442
Assembly Biosciences Inc	1,025,273.97	$ 74.845 Million	73
Sanara Medtech Inc	1,019,592.91	$ 110.116 Million	108
Ani Pharmaceuticals Inc	1,008,638.14	$ 978.379 Million	970
Coya Therapeutics Inc	1,002,393.13	$ 8.019 Million	8
Meiragtx Holdings Plc	986,354.84	$ 397.501 Million	403
Evolus Inc	949,440.12	$ 317.113 Million	334
Arrowhead Pharmaceuticals Inc	941,624.47	$ 669.495 Million	711
Scilex Holding Company	929,647.06	$ 31.608 Million	34
Ardelyx inc	922,073.62	$ 450.894 Million	489
The Oncology Institute Inc	916,137.29	$ 587.244 Million	641
Pacira Biosciences inc	900,077.20	$ 746.164 Million	829
Fortress Biotech Inc	897,217.95	$ 69.983 Million	78
Alphatec Holdings Inc	892,420.59	$ 814.780 Million	913
Merck and Co Inc	887,586.67	$ 66,569.000 Million	75,000
Nektar Therapeutics	866,492.06	$ 54.589 Million	63
Verastem Inc	858,098.04	$ 87.526 Million	102
Emergent Biosolutions Inc	855,777.78	$ 770.200 Million	900
Bridgebio Pharma Inc	849,903.46	$ 713.069 Million	839
Pfizer Inc	849,280.00	$ 63,696.000 Million	75,000
Syndax Pharmaceuticals Inc	845,651.01	$ 252.004 Million	298
Xilio Therapeutics Inc	843,315.79	$ 64.092 Million	76
Axsome Therapeutics Inc	839,534.05	$ 776.569 Million	925
Ionis Pharmaceuticals Inc	834,107.70	$ 1,169.419 Million	1,402
Vir Biotechnology Inc	826,231.61	$ 303.227 Million	367
Immunocore Holdings Plc	822,089.69	$ 430.775 Million	524
Prothena Corporation Public Limited Company	813,880.60	$ 54.530 Million	67

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.